• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

68.32 +0.10 (+0.15%)
Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,064,895
Open 67.00
Bid (Size) 66.66 (200)
Ask (Size) 66.87 (100)
Prev. Close 68.22
Today's Range 66.35 - 71.35
52wk Range 40.77 - 97.25
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
October 13, 2026
From Ambry Genetics
Via Business Wire
News headline image
Tempus Announces Multi-Year Collaboration with Moderna and Merck
October 07, 2026
From Tempus
Via Business Wire

Performance

52-Week Range 29.7% below 52-week high
68.32
40.7752W Low 97.2552W High
1 Week 6.4% below 1-week high
66.171W Low 72.961W High

Tempus AI, Inc. - Class A Common Stock (TEM) traded between $40.77 and $97.25 over the past 52 weeks and last traded at $68.32, 29.7% below its 52-week high. Over the past week it ranged between $66.17 and $72.96.

Past 12 Months
-1.4%
+9.8%
+19.3%
+21.1%
+9.6%
-24.0%
1W -$0.96
1M +$6.11
3M +$11.07
6M +$11.91
YTD +$5.96
1Y -$21.55

TEM was -24.0% over the past year, +21.1% over six months, +9.6% year to date, -1.4% in the last week.

12 Months vs Market
TEM
-24.0%
DIA
+11.4%
SPY
+16.2%
QQQ
+21.9%
IWM
+9.5%

Over the past 12 months TEM returned -24.0% versus DIA (Dow) +11.4%, SPY (S&P 500) +16.2%, QQQ (Nasdaq 100) +21.9% and IWM (Russell 2000) +9.5%.

Volume & Liquidity 0.89× 3-mo avg
Today 6,064,895 3-mo avg 6.8M
1W
5.5M
1M
7.6M
3M
6.8M
6M
6.7M
YTD
6.2M
1Y
6.0M

TEM most recently traded 6,064,895 shares against a 3-month average daily volume of 6.8M.

More News

Read More
News headline image
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
October 01, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
September 28, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI Chief Accounting Officer Sells $529,650 of Stock ↗
September 24, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion ↗
September 21, 2026
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model
September 21, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
September 11, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology
September 09, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
September 09, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
September 04, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
September 03, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000 ↗
September 02, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Cathie Wood Invested Roughly $1.4 Billion of Ark Invest's Flagship ETF in Just 3 Artificial Intelligence (AI) Stocks ↗
August 28, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Earnings
News headline image
Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
August 24, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Why Tempus AI Skyrocketed This Week ↗
August 23, 2026
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
A Tempus AI Director Sold Stock Four Days Before a 24% Rally. Here's What to Know ↗
August 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Is Tempus AI Stock a Buy After Its 75% Rally? Here's What to Know as the Firm's Legal Chief Files a Trade ↗
August 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Accounting Chief Just Reported an Insider Transaction. Here's What Long-Term Investors Should Know ↗
August 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
What to Know About the CFO of Tempus AI's Latest Insider Transaction Filing ↗
August 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Diagnostics Chief Filed Stock Sales Spanning a Volatile Week. Here's What Happened ↗
August 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Data Chief Just Filed a Form 4. His Segment Grew 28% Last Quarter. ↗
August 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's CEO Sold $6.6 Million in Stock the Day Before a Huge Rally. Here's What to Know ↗
August 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
AI Found an Influenza Target That Survives Viral Mutation
August 10, 2026
From Equity Insider
Via GlobeNewswire
News headline image
Why Is Tempus AI Stock Surging on Friday? ↗
August 07, 2026
Via Benzinga
Topics Artificial Intelligence

Frequently Asked Questions

Is Tempus AI, Inc. - Class A Common Stock publicly traded?
Yes, Tempus AI, Inc. - Class A Common Stock is publicly traded.
What exchange does Tempus AI, Inc. - Class A Common Stock trade on?
Tempus AI, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tempus AI, Inc. - Class A Common Stock?
The ticker symbol for Tempus AI, Inc. - Class A Common Stock is TEM on the Nasdaq Stock Market
What is the current price of Tempus AI, Inc. - Class A Common Stock?
The current price of Tempus AI, Inc. - Class A Common Stock is 68.32
When was Tempus AI, Inc. - Class A Common Stock last traded?
The last trade of Tempus AI, Inc. - Class A Common Stock was at 10/14/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap